Pay in 4 interest-free payments of $6.36 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
This large-scale analysis suggests that OSA status may act as an effect modifier in the association between GLP-1-RA prescription and mortality. The results of this study may lead to OSA diagnosis identifying diabetes patients more likely to derive mortality benefit from GLP-1 therapythe 20% greater relative mortality reduction in patients with OSA supports considering OSA status when making GLP-1 prescribing decisions, the investigators say
Other strengths of our trial include the acquisition of full monitoring data
Independent retrospective studies by Kawata et al
Radical-induced lipid oxidation produces a torrent of leukotriene-like agonists in severe asthma
A total of 145 participants (33.1% with type 2 diabetes) were randomly assigned to once weekly efinopegdutide 10 mg or semaglutide 1 mg following dose titration
US$ 22.78
US$ 20.65
US$ 24.55
US$ 22.46
)
US$ 21.73
